LYG-202

CAT: 0804-HY-115436-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-115436-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
LYG-202, a flavonoid, has potent anti-angiogenic and antitumor activity. LYG-202 inhibits VEGF-stimulated HUVEC migration and tube formation. LYG-202 induces cancer cell apoptosis[1][2].
CAS Number
[1175077-25-4]
UNSPSC
12352005
Hazard Statement
H301
Target
Apoptosis
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/lyg-202.html
Purity
99.04
Solubility
DMSO : 5 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C1C=C(C2=CC=CC=C2)OC3=C(OC)C(OCCCCN4CCN(C)CC4)=CC(O)=C13
Molecular Formula
C25H30N2O5
Molecular Weight
438.52
Precautions
H301
References & Citations
[1]Chen Y, et al. LYG-202, a newly synthesized flavonoid, exhibits potent anti-angiogenic activity in vitro and in vivo. J Pharmacol Sci. 2010;112 (1) :37-45.|[2]Zhao Y, et al. LYG-202 exerts antitumor effect on PI3K/Akt signaling pathway in human breast cancer cells. Apoptosis. 2015 Sep;20 (9) :1253-69.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-170952-01LYG-409
HY-124540ABT-202
HY-P991437FM-202
HY-178861DCDK9-202
HY-P991363-01AX-202
HY-19745-01BMS-202
HY-W287494Antitumor agent-202
HY-101522-01CHMFL-EGFR-202
HY-W1008871CRBN ligand-202
HY-161404Antibacterial agent 202

Alternative Products

CatalogName
sc-396595LYG-202
C03615-01LYG-409
A24461-10LYG-409 10mg
A24461-5LYG-409 5mg
A24461-50LYG-409 50mg
A24461-100LYG-409 100mg
MBS385200-014SC-202
2022/10SR 202
sc-57613Amitriptyline (202)
BUP17210-01RGX-202

Popular Products